Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 31722-712

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 31722-712). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camberlogo1

FDA Label Image

Camberlogo2

FDA Label Image

Pantocontlabel20mg

This is a medication, Pantoprazole Sodium, produced by Camber Pharmaceuticals, Inc. The medication is in the form of delayed-release tablets that can’t be chewed, split, or crushed and must be stored at 20°C to 25°C. The usual dosage for the drug is mentioned in the package insert. The text encourages pharmacists to provide a medication guide to every patient.*

FDA Label Image

Pantocontlabel40mg

This is a label on a package of Pantoprazole Sodium Delayed-Release Tablets USP manufactured by Hetero Labs Limited for Camber Pharmaceuticals, Inc. The package contains 90 enteric-coated tablets, each containing Pantoprazole 40 mg. This medication is intended for prescription-only to treat acid reflux and other similar conditions. The package insert includes the full prescribing information and the recommended dosage. The tablets should not be split, chewed or crushed before administration. A medication guide is enclosed, which should be provided to each patient. Store in a controlled room temperature of 20° to 25°C.*

FDA Label Image

Structure.jpg (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.